[1] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima, Japan
[2] Asahi Life Fdn, Inst Adult Dis, Chuo Ku, 2-2-6 Bakuro Cho, Tokyo 1030002, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan
[4] Nippon Boehringer Ingelheim Co Ltd, Dept Mol & Cellular Biol, Kobe Pharma Res Inst, Chuo Ku, 6-7-5 Minatoshimaminami Cho, Kobe, Hyogo 6500047, Japan
[5] Hiroshima Univ, Dept Mol Oncol, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan
[6] Hiroshima Univ, Leukemia Program Project, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan
[7] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent Sci Hlth Promot, Div Cervicognathostomatol,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi, Japan
[8] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 980, Japan
[9] Yakult Honsha Co Ltd, Yakult Cent Inst, 5-11 Izumi, Kunitachi, Tokyo 1868650, Japan